Symptom patterns and comparison of diagnostic methods in ragweed pollen allergy

Exp Ther Med. 2021 May;21(5):525. doi: 10.3892/etm.2021.9957. Epub 2021 Mar 22.

Abstract

The aim of the present study was to determine the pattern of symptoms of ragweed pollen-induced allergic disease in sensitized patients from Romania and to compare the molecular diagnosis of allergy with the skin prick test, in order to better characterize allergic patients and to guide therapy. A total of 97 subjects, including patients with ragweed pollen-induced allergic rhinoconjunctivitis with/without asthma, as well as healthy controls, were recruited prospectively in one ragweed pollen season, submitted to allergy questionnaires, skin prick tests and multiplex specific IgE (immunoglobulin E) measurement by ImmunoCAP ISAC (ImmunoCAP Immuno-Solid phase Allergy Chip) assay. A total of 83 patients were sensitized to ragweed pollen. Most patients (73%) were diagnosed with moderate-severe intermittent allergic rhinoconjunctivitis and 25% of the patients also had allergic asthma. The most common symptoms were watery rhinorrhea (91.57%), nasal obstruction (86.75%), and sneezing (85.54%). Most patients were polysensitized (62.65%), especially to other pollens, house dust mites and animal danders. Only 90% of the patients with positive skin prick test to ragweed pollen extract also had increased specific serum IgE to Amb a 1. Current options for specific molecular diagnosis of ragweed allergy are limited, as they only contain one or few of the sensitizing allergens present in ragweed pollen. An improved component-resolved diagnosis, using several ragweed pollen allergens, is required for better patient characterization and subsequent selection of an appropriate allergen immunotherapy product, thereby enabling a more personalized approach to the management of the ragweed-allergic patient.

Keywords: IgE; ImmunoCAP ISAC assay; allergic rhinoconjunctivitis; molecular diagnosis; ragweed pollen allergy; skin prick test.

Grants and funding

Funding: This work was supported through the project ‘INnovative Strategies for Prevention, diagnosis and therapy of ragweed pollen Induced REspiratory Diseases’ (INSPIRED), MySMIS 103663, COP 2014-2020 92/09.09.2016, funded by the National Authority for Scientific Research and Innovation (ANCSI), under the Operational Program Competitiveness 2014-2020.